1571-99-9 Usage
Description
2-Pyridin-3-yl-1H-benzo[d]imidazole-5-ylamine is a heterocyclic aromatic organic compound characterized by a pyridine ring fused to a benzimidazole ring. With the chemical structure C11H9N5, this compound holds potential in medicinal chemistry, particularly for the development of pharmaceutical drugs. Its unique structural features suggest it may possess biologically active properties, making it a significant molecule for research and development in the creation of new medications to address various diseases.
Uses
Used in Pharmaceutical Development:
2-Pyridin-3-yl-1H-benzo[d]imidazole-5-ylamine is used as a key component in the development of pharmaceutical drugs due to its potential biologically active properties. Its heterocyclic structure allows for versatile interactions with biological targets, which may contribute to the discovery of new therapeutic agents.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, 2-Pyridin-3-yl-1H-benzo[d]imidazole-5-ylamine is utilized as a subject of study to explore its specific biological activities and potential therapeutic uses. Ongoing research aims to understand its interactions with biological systems and how it can be harnessed for the treatment of various diseases.
Check Digit Verification of cas no
The CAS Registry Mumber 1571-99-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,5,7 and 1 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1571-99:
(6*1)+(5*5)+(4*7)+(3*1)+(2*9)+(1*9)=89
89 % 10 = 9
So 1571-99-9 is a valid CAS Registry Number.
InChI:InChI=1/C12H10N4/c13-9-3-4-10-11(6-9)16-12(15-10)8-2-1-5-14-7-8/h1-7H,13H2,(H,15,16)
1571-99-9Relevant articles and documents
Divergent Late-Stage (Hetero)aryl C?H Amination by the Pyridinium Radical Cation
Ham, Won Seok,Hillenbrand, Julius,Jacq, Jér?me,Genicot, Christophe,Ritter, Tobias
supporting information, p. 532 - 536 (2019/01/04)
(Hetero)arylamines constitute some of the most prevalent functional molecules, especially as pharmaceuticals. However, structurally complex aromatics currently cannot be converted into arylamines, so instead, each product isomer must be assembled through a multistep synthesis from simpler building blocks. Herein, we describe a late-stage aryl C?H amination reaction for the synthesis of complex primary arylamines that other reactions cannot access directly. We show and rationalize through a mechanistic analysis the reasons for the wide substrate scope and the constitutional diversity of the reaction, which gives access to molecules that would not have been readily available otherwise.
